Impella CP Improves Survival in STEMI, Cardiogenic Shock
Use of a microaxial flow pump led to a lower risk of death in patients with STEMI-related cardiogenic shock in the DanGer Shock trial, although with more adverse events.
Medscape Medical News
source https://www.medscape.com/viewarticle/impella-cp-improves-survival-stemi-cardiogenic-shock-2024a10006kz?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/impella-cp-improves-survival-stemi-cardiogenic-shock-2024a10006kz?src=rss
Comments
Post a Comment